Atrasentan - CISMeF

Preferred Label : Atrasentan;

NCIt synonyms : (2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid; Atrasentan Base;

Alternative definition : NCI-GLOSS: A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists.;

UNII : V6D7VK2215;

InChIKey : MOTJMGVDPWRKOC-QPVYNBJUSA-N;

CAS number : 173937-91-2;

Chemical formula : C29H38N2O6;

Codes from synonyms : 50514; CDR0000045029;

Details

Origin ID

C61606;

UMLS CUI

C0935914;

Currated CISMeF NLP mapping
- Atrasentan [MeSH Descriptor]
- atrasentan [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Atrasentan [MeSH Descriptor]
- atrasentan [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Atrasentan Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Atrasentan Hydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients